
Influenza A Virus M2 antibody detects M2 protein at by immunofluorescent analysis. Sample: A/WSN/33 infected Vero cells were fixed in 4% paraformaldehyde at RT for 20 min. Green: M2 protein stained by Influenza A Virus M2 antibody (GTX125951) diluted at 1:500. Blue: DAPI staining. Yellow: WGA life stained at 37oC,?30 min.
Influenza A virus M2 (matrix protein) antibody
GTX125951
ApplicationsElectron Microscopy, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameInfluenza A virus M2 (matrix protein) antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsElectron Microscopy, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.61 mg/ml
- ConjugateUnconjugated
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Han YJ, Lee KM, Wu GH, et al. Targeting influenza A virus by splicing inhibitor herboxidiene reveals the importance of subtype-specific signatures around splice sites. J Biomed Sci. 2023,30(1):10. doi: 10.1186/s12929-023-00897-4Read this paper
- Choi S, Yang Z, Wang Q, et al. Displaying and delivering viral membrane antigens via WW domain-activated extracellular vesicles. Sci Adv. 2023,9(4):eade2708. doi: 10.1126/sciadv.ade2708Read this paper
- Li Q, Jiang Z, Ren S, et al. SRSF5-Mediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A Host-Directed Target Against Influenza Virus. Adv Sci (Weinh). 2022,9(34):e2203088. doi: 10.1002/advs.202203088Read this paper
- Wu W, Wang C, Xia C, et al. MicroRNA let-7 Suppresses Influenza A Virus Infection by Targeting RPS16 and Enhancing Type I Interferon Response. Front Cell Infect Microbiol. 2022,12:904775. doi: 10.3389/fcimb.2022.904775Read this paper
- Wang G, Zhao Y, Zhou Y, et al. PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence. PLoS Pathog. 2022,18(4):e1010446. doi: 10.1371/journal.ppat.1010446Read this paper
- Ulferts R, Marcassa E, Timimi L, et al. Subtractive CRISPR screen identifies the ATG16L1/vacuolar ATPase axis as required for non-canonical LC3 lipidation. Cell Rep. 2021,37(4):109899. doi: 10.1016/j.celrep.2021.109899Read this paper
- Mao X, Gu S, Sang H, et al. Essential Oil-Rich Chinese Formula Luofushan-Baicao Oil Inhibits the Infection of Influenza A Virus through the Regulation of NF-κB P65 and IRF3 Activation. Evid Based Complement Alternat Med. 2021,2021:5547424. doi: 10.1155/2021/5547424Read this paper
- Hara H, Chida J, Uchiyama K, et al. Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells. Sci Rep. 2021,11(1):10109. doi: 10.1038/s41598-021-89586-6Read this paper
- Kwon EB, Yang HJ, Kim YS, et al. 8-O-(E-p-methoxycinnamoyl)harpagide Inhibits Influenza A Virus Infection by Suppressing Intracellular Calcium. Molecules. 2021,26(4). doi: 10.3390/molecules26041029Read this paper
- Chida J, Hara H, Uchiyama K, et al. Prion protein signaling induces M2 macrophage polarization and protects from lethal influenza infection in mice. PLoS Pathog. 2020,16(8):e1008823. doi: 10.1371/journal.ppat.1008823Read this paper





